Insider Trading - Pontifax (China) IV L.P.

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Pontifax (China) IV L.P.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-03-21
Purchase
2018-03-23
4:16 pm
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (China) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax IV GP L.P.
10% Owner
12,600 $7.7643 $97,830 427,063
(Indirect)
View
2018-04-30
Purchase
2018-05-01
4:37 pm
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (China) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax IV GP L.P.
10% Owner
350,000 $9.75 $3,412,500 520,396
(Indirect)
View
2019-06-24
Purchase
2019-06-26
4:44 pm
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (China) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax IV GP L.P.
10% Owner
200,000 $9 $1,800,000 24,000
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:18 pm
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
437,499 $16 $6,999,984 149,262
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:38 pm
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
60,000 $50 $3,000,000 155,262
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:39 pm
Keros Therapeutics Inc. KROS Kariv Tomer
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner
60,000 $50 $3,000,000 155,262
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:40 pm
Keros Therapeutics Inc. KROS Nussbaum Ran
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner
60,000 $50 $3,000,000 155,262
(Indirect)
View
2021-05-13
Purchase
2021-05-17
07:03 am
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (China) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax IV GP L.P.
10% Owner
5,925,925 $1.35 $7,999,999 616,592
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2018-06-15
Option Award
2018-06-19
6:19 pm
N/A
2028-06-15
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax IV GP L.P.
10% Owner
40,000 $0 40,000
(Indirect)
View
2018-06-15
Option Award
2018-06-19
6:19 pm
N/A
2028-06-15
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax IV GP L.P.
10% Owner
40,000 $0 40,000
(Indirect)
View
2019-05-29
Option Award
2019-05-29
5:15 pm
N/A
2029-05-29
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax IV GP L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax Management III G.P. (2011) Ltd.
Pontifax Management Fund III L.P.
Pontifax (Cayman) III L.P.
Pontifax (Israel) III L.P.
10% Owner
20,000 $0 20,000
(Indirect)
View
2019-05-29
Option Award
2019-05-29
5:15 pm
N/A
2029-05-29
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax IV GP L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax Management III G.P. (2011) Ltd.
Pontifax Management Fund III L.P.
Pontifax (Cayman) III L.P.
Pontifax (Israel) III L.P.
10% Owner
20,000 $0 20,000
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
1,363,542 $0 1,734,395
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
663,825 $0 844,371
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
737,226 $0 937,735
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
169,307 $0 1,903,702
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
82,425 $0 926,796
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
91,538 $0 1,029,273
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
68,654 $0 68,654
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
163,612 $0 2,067,314
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
88,460 $0 1,015,256
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
79,653 $0 1,108,926
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
36,858 $0 105,512
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
1,363,542 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
663,825 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
737,226 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
169,307 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
82,425 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
91,538 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
68,654 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
163,612 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
88,460 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
79,653 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
36,858 $0 0
(Indirect)
View
2020-05-20
Option Award
2020-05-22
4:10 pm
N/A
2030-05-20
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax IV GP L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax Management III G.P. (2011) Ltd.
Pontifax Management Fund III L.P.
Pontifax (Cayman) III L.P.
Pontifax (Israel) III L.P.
10% Owner
20,000 $0 20,000
(Indirect)
View
2020-05-20
Option Award
2020-05-22
4:10 pm
N/A
2030-05-20
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax IV GP L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax Management III G.P. (2011) Ltd.
Pontifax Management Fund III L.P.
Pontifax (Cayman) III L.P.
Pontifax (Israel) III L.P.
10% Owner
20,000 $0 20,000
(Indirect)
View